Pine Lake Investments, Inc.
An establishment registered with the FDA. No drug label names this site as performing a manufacturing step; labels list it for other roles (packing, labeling, repackaging or testing), which are shown below.
- Country
- United States
- Registered address
- 719 Middle St, Bristol, Connecticut (CT) 06010, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 3003612465 · DUNS 081060270
FDA inspection history
Outcomes of closed FDA inspections at this site, every FDA program area; the official-action banner above considers Drug Quality Assurance inspections only.
- NAIDrug Quality Assurance2026-07-01
- NAIDrug Quality Assurance2021-03-18
- VAIDrug Quality Assurance2016-03-08
- NAIDrug Quality Assurance2011-04-28
- VAIDrug Quality Assurance2009-03-18
Drugs this plant is listed as making
0 distinct drugs across 0 products name this site for a manufacturing step (any MANUFACTURE-type role, API included); 1 more list it only for packing, labeling, repackaging or testing. Counts are per distinct generic name (case-insensitive).
No drug label names this site as a manufacturing site.
Listed for other roles only
- Methadone Hydrochlorideanalysis
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.